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Abstract
Background: The symposium entitled “Chernobyl +30, Fukushima +5: Lessons and Solutions for Fukushima’s
Thyroid Question” was held in September, 2016 in Fukushima. The aim of the Symposium was to revisit and
recapitulate evidence from the studies in Chernobyl in order to share multidisciplinary opinions and views on
the likely reason for the high rate of thyroid cancer detected by the Thyroid Ultrasound Examination program
in Fukushima Prefecture.
Participants and matters discussed: The high prevalence of thyroid cancer in young individuals causes concerns
among Fukushima residents and the general public that it might be due to putative radiation exposure from the
Fukushima Daiichi Nuclear Power Plant accident. Twenty-six experts from Japan and abroad, including participants
affiliated with international organizations, reviewed the results of radiation epidemiology investigations in
Chernobyl, presented clinical experience of diagnosis, treatment and follow-up of patients with radiation-related
thyroid cancer, and scrutinized the findings on thyroid cancer in Fukushima.
Conclusion: Conclusions drawn at the symposium included understanding that in contrast to Chernobyl, doses to
the public from the accident in Fukushima were too low to give rise to a discernible excess risk for thyroid cancer.
The high detection rate of thyroid cancer and benign abnormalities resulted from the use of highly sensitive
ultrasound equipment and sophisticated protocol of examination used in the Thyroid Ultrasound Examination,
and therefore not attributable to radiation. Coordinated efforts will be necessary to avoid overdiagnosis and
overtreatment, which may carry its own health disbenefits. Clear communication to the screening participants
and their families is recommended in regard to why the examination is being conducted and to explain the
likely outcomes and risks, including the means and options for treatment if a thyroid disorder is detected.
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Background
Two thousand sixteen marks the 30th anniversary of the
Chernobyl and the 5th anniversary of the Fukushima
Daiichi Nuclear Power Plant (NPP) accidents. These two
dramatic events in different countries, separated in
time by 25 years, have been rated 7th level, i.e., a
“Major accident”, according to the International
Atomic Energy Agency’s (IAEA) International Nuclear
and Radiological Event Scale [1]. Although atmospheric
releases of radionuclides have been eventually determined
to be at least an order of magnitude lower in Fukushima
than those in Chernobyl [2], an uncertainty in potential
exposure doses during the acute phase of the crisis in
Fukushima led to emergency response, which initially
involved evacuation of some 165,000 residents living in
the 30 km zone around the plant. The potential of an
involuntary exposure to radiation, and concerns about its
potential health effects, resulted in the establishment of
the Fukushima Health Management Survey Program
[3], one of four components of which is the Thyroid
Ultrasound Examination (TUE) launched in October
2011 [4]. The high prevalence of thyroid cancer among
young individuals aged 0–18 years as of April 1, 2011
in TUE [5] detected by the sensitive methods further
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augmented fears and anxiety about the relationship of
thyroid cancer to radiation in Fukushima. Since the
studies on health consequences of the Chernobyl acci-
dent in exposed population performed during the last
30 years are a unique source of knowledge to assess
whether an evidence-based link between radiation releases
and thyroid cancer in young residents in Fukushima may
exist, the Symposium convened on September 26–26,
2016, revisiting data from Chernobyl and Fukushima from
the point of view of different scientific disciplines to offer
insights into the reasons for the seemingly high detection
rate of thyroid cancer in Fukushima. Lists of the Organiz-
ing Committee members, and of the chairpersons and
participants of the Symposium are provided in Additional
file 1 and Additional file 2, respectively.
Thyroid cancer in the regions affected by the
Chernobyl accident
The Chernobyl studies reviewed included those on epi-
demiology and long-term clinical outcomes of treatment
of young patients with thyroid cancer.
Detectable excess risk for thyroid cancer as a result of
radiation exposure in the individuals aged less than
18 years at the time of the Chernobyl accident is well-
established to exist. It is for this reason that the age of 18
at the time of the accident was used to determine the age
inclusion criterion in Fukushima TUE. Prospective cohort
studies in Ukraine, Belarus and Russia concur that the risk
remains elevated even until today, i.e., 30 years after the
accident. However, as the UkrAm study shows, excess
relative risk per dose unit is declining with time in each
consequent round of ultrasound screening [6], and is ac-
companied by time-dependent pathomorphological evolu-
tion of tumor characteristics to the less aggressive
phenotype with corresponding molecular genetic changes
[7]. In the individuals exposed at young age in Ukraine
and Russia who then developed thyroid cancer, mean radi-
ation doses to the thyroid ranged 0.4–3.4 Gy or exceeded
0.2 Gy, respectively [6, 8], which is an important fact in
view of low thyroid doses in Fukushima [9–11]. Also of
relevance to the Fukushima scenario, a significant
screening effect was found in the Chernobyl cohort, ac-
counting for a 6.74-fold increase, on average, in the de-
tection rate of thyroid cancer during the 20-year long
period of observation since 1991. The size of screening
effect appears to decrease with time being the highest
during the first 5 years of the study. If it was postulated
that a similar effect on thyroid cancer rate would be
observed in Fukushima, it could be predicted that the
frequency of expected thyroid cancers occurring as a
result of the TUE would be similar to those actually ob-
served [12].
Pathological studies indicate that radiation-induced thy-
roid cancers may display more aggressive morphological
features than sporadic tumors in age-matched groups of
patients, especially among children [13]. The major differ-
ences between radiogenic and sporadic papillary thyroid
carcinoma, which is the only type of thyroid cancer whose
incidence increased sharply after the Chernobyl accident
in young patients, include the lower female-to-male ratio
and a higher rate of distant metastases in radiogenic can-
cer, and a higher frequency of co-existing thyroid diseases
in sporadic tumors [13, 14]. Importantly, however, the
higher morphological aggressiveness of radiation-induced
thyroid cancer does not bring about a worse clinical out-
come. Indeed, radiation history does not appear to signifi-
cantly affect long-term treatment results, provided an
appropriate, not principally different from that for spor-
adic thyroid cancer treatment and follow-up had been per-
formed [15]. Despite the advanced stage of disease and
sub-optimal initial management, response to radioiodine
therapy and final outcomes are favorable in the vast ma-
jority of Chernobyl patients [16]. Results of long-term
follow-up confirm overall good prognosis and a low fre-
quency of side effects in young individuals receiving high
doses of radioiodine therapy for thyroid cancer. Thyroid
ultrasound screening may also lead to the earlier detection
of smaller tumors and result in a better recurrence-free
survival in children and adolescents with PTC.
Thyroid cancer detected during TUE in Fukushima
Clinical approaches to treating thyroid cancer in Japan
and Western countries have some differences. In Japan, a
surgical procedure for low-risk thyroid cancer is rather
conservative, generally preserving patients’ quality of life,
and postoperative management does not widely involve
radioiodine therapy. Such a risk-adapted management
strategy is based on the analysis of long-term outcomes in
patients who had received treatment for thyroid cancer in
the country.
The initial screening (1st survey) of the TUE was
finished in March 2014, and the full-scale thyroid
screening program (2nd survey) – in March 2016;
currently the 3rd survey is ongoing since April 2016.
The number of patients with malignant or suspected
malignant nodules accounted for 116 (among 300,476
examined) and 59 (among 270,327) individuals in the 1st
and 2nd surveys, respectively [17, 18].
By the end of September 2016, 127 patients were given
thyroid surgery in Fukushima Medical University Hospital.
Strict criteria for fine-needle aspiration biopsy are applied
to avoid overdiagnosis. For low-risk nodules, including
small preclinical thyroid cancers, when regional or distant
metastasis is not detected nor extrathyroidal extension is
observed, the watch tactics may be recommended. Among
the patients with detected thyroid nodules, 39 are now
waiting for surgical treatment or preferred nonsurgical ob-
servation. A particularity of patients in Fukushima is that
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they are young, age range 9 – 23 years so far and
asymptomatic. Whether the watch-and wait tactics in
such young patients, especially in children, is appropri-
ate remains to be determined. There is a real need in
preparing guidelines for management of thyroid cancer
in children and adolescents in Japan.
Comparison of thyroid cancer cases in Fukushima
with data from Chernobyl areas demonstrates a large dif-
ference in age distributions of patients from Fukushima
and Chernobyl after a period of latency, where the highest
risk for thyroid cancer was observed in the individuals of
preschool age at exposure [19, 20]. In addition, thyroid
doses in Fukushima are also low compared to those in
Chernobyl [9–11] and there is no difference in the preva-
lence of thyroid cancer in different areas of Fukushima
Prefecture with different levels of radioactive contamin-
ation [5], which was clearly seen in Chernobyl [21]. These
circumstances strongly suggest that radiation etiology of
these tumors is very unlikely, which is important for the
residents of Fukushima Prefecture.
There is a consensus among the professionals in Japan
that detecting subclinical thyroid cancer in mass screen-
ing of the general population is not beneficial. In part
due to this, the increase in thyroid cancer incidence in
the country was not as dramatic as in Korea or in the
USA. Mass screening inevitably increases the detection
rate of thyroid cancer, and it is essential to properly
communicate to the population under screening and to
consider previous experience of screenings in Japan and
other countries [22] to judge about health benefits of
currently ongoing programs. Another important point is
that TUE was started in response to the demands of
Fukushima residents concerned about potential radiation
effects on their health. While the specialists and profes-
sionals realize that due to biological particularities of
well-differentiated thyroid cancer, early diagnosis and
treatment of small tumors will unlikely decrease cause-
specific mortality, it is essential to deliver this message
to the residents in order they better understand benefits
and harms of thyroid screening. The current situation
reveals a number of challenges, which to be solved need
engagement from all stakeholders, advocating of the vol-
untary basis of participation in health survey, reduction
of overdiagnosis, and communication regarding possible
disbenefits of overdiagnosis and overtreatment.
Role of the international organizations
International organizations, including the World Health
Organization (WHO), United Nations Scientific Committee
on the Effects of Atomic Radiation (UNSCEAR), Inter-
national Commission on Radiological Protection (ICRP),
IAEA and International Agency for Research on Cancer
(IARC), have been taking an active part in research post
Fukushima since the very beginning of the crisis, and have
provided their expertise in evaluation of radiological
risks and health effects of the Daiichi NPP accident.
The WHO, UNSCEAR and IAEA performed health risk
assessment for the population and NPP workers based
on the information available at the time of publication
[2, 23, 24]. The IAEA report was chronologically the
latest and based on the most updated information.
Despite some discrepancy in dose estimates between
the reports and, consequently, health risk projections,
their conclusions are similar: in contrast to Chernobyl,
public doses from the accident were low, and occupational
doses were within the regulatory limits (an effective dose
of 20 mSv per year averaged over five consecutive years,
i.e., 100 mSv in 5 years, and of 50 mSv in any single year
[25]). Therefore, no immediate health effect attributable
to radiation occurred, and no discernible radiation-related
health effects are expected in exposed population and
their descendants [2, 24].
ICRP has played a prominent role in establishing tight
links with Fukushima Medical University to facilitate joint
activities on meeting day-to-day challenges that the resi-
dents of Fukushima Prefecture face. A key point of ICRP
activities has been engaging wide circles of stakeholders in
the discussion and decision making process in contami-
nated areas, emphasizing the role of people exposed to
radiation, and bringing in the ethical dimension to the
concept of radiological protection.
IARC underscored the role of scientific research in
understanding the mechanisms of radiation-related car-
cinogenesis. Further studies are necessary to identify host
and environmental factors that may confound or modify
radiation effects on human thyroids, to understand what
causes progression or regression of thyroid tumors and to
seek molecular signatures of radiation-induced thyroid
cancer. All this will contribute to the development of risk-
adapted approaches to diagnosis and treatment.
The continuous support of the international organization
since the accident has been essential and will be indispens-
able for the future of recovery in Fukushima Prefecture at
all levels in society.
Conclusions
The Symposium arrived at the following conclusions.
1) The Fukushima Health Management Survey Program
is based on surveys with the purpose of long-term
health care of prefectural residents and is being
carried out in response to their concerns. The
health survey was designed to be a study of the
health situation of the residents of Fukushima
prefecture but it was not intended to be a scientific
and epidemiological study of a radiation risk in
respect of thyroid cancer. Such an “epidemiological”
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study would have been long and difficult, would not
have responded to the needs expressed by the
population and therefore was not considered
necessary.
2) Experience from Chernobyl suggests that any
increase in thyroid cancer due to radiation exposure
would be observed first in those who were very
young (0–4 years of age) at the time of the accident,
and that any increase would not be observed until
4–5 years after exposure to radiation. It would be
predicted therefore that if radiation were the cause
of any increase in thyroid cancer in Fukushima,
more cases would be observed in the youngest
participants of the TUE. To date, thyroid cancers
were found in children in their late teenage years,
but no cases were found in the most vulnerable
group of very young children, which further
suggests that the increase is due to a screening
rather than radiation exposure. Any cancer takes
a period of time from the genotoxic insult that
initiates it to detection, even by sensitive techniques
such as those used in the TUE. If the increase in
thyroid cancer abnormalities seen in the first
round of the TUE were to result from exposure to
radiation from the accident, an abnormally shorter
latency than that observed post Chernobyl would
be taking place. This would seem to be a highly
unlikely scenario. The proportion of suspicious
or malignant cases was almost the same among
regions in Fukushima Prefecture. If due to
radiation, there should be a relative increase
in those areas of the Prefecture with higher
radiation exposure.
3) The TUE uses highly sensitive ultrasound
sonography equipment for screening the thyroid
and routinely detects asymptomatic thyroid
abnormalities such as nodules and cysts.
Ultrasound thyroid screening of asymptomatic
individuals has the potential to do more harm
than good to the population, and should only be
carried out when clear benefits to the population
can be defined; participation in the health surveys
and the thyroid screening program must therefore
be voluntary. The reasons for the high background
rate of thyroid abnormalities, whether malignant
or benign, detected in the course of TUE in
Fukushima Prefecture in young individuals requires
explanation to the non-specialist audience. Clear
communication to the screening participants and
their families is needed in regard to why the
examination is being conducted and the likely
outcomes and risks, including the means and
options for treatment if a thyroid disorder is
detected.
The major message of the Symposium was that the
current findings of the TUE in Fukushima Prefecture are
not attributable to radiation.
Additional files
Additional file 1: Members of the Organizing Committee of the 5th
International expert symposium in Fukushima on radiation and health (in
alphabetical order). (DOC 30 kb)
Additional file 2: Chairpersons and speakers of the 5th International
expert symposium in Fukushima on radiation and health (in alphabetical
order). (DOC 42 kb)
Abbreviations
Gy: Gray; IAEA: International Atomic Energy Agency; IARC: International
Agency for Research on Cancer; ICRP: International Commission on
Radiological Protection; NPP: Nuclear power plant; TUE: Thyroid Ultrasound
Examination; UNSCEAR: United Nations Scientific Committee on the Effects




The symposium was organized by The Nippon Foundation, co-organized by
Fukushima Medical University, Nagasaki University, Sasakawa Memorial health
Foundation, and supported in part by The Nippon Foundation, Fukushima
Prefecture, Hiroshima University, Japan Medical Association, Japanese Nursing
Association and Japan Pharmaceutical Association. Publication of this article
was supported in part by JSPS KAKENHI Grant Number 16H02774. The funding
sources had no involvement in the content of the Symposium or preparation
of the report.
Availability of data and materials
Materials of the Symposium, including the program, abstracts and slides in
PDF format, and video records of presentations are available from Fukushima
Medical University website (http://fmu-global.jp/workshop/symposium/26-27-
sep-2016-5th-intl-expert-symposium-in-fukushima-2/). A special volume
entitled “Thyroid Cancer and Nuclear Accidents – Long-term After Effects of
Chernobyl and Fukushima” containing articles specially written for it by the
experts participating in the Symposium is expected to be published by
Elsevier in March, 2017 with the support of The Nippon Foundation.
Authors’ contributions
VAS and GAT contributed to the Symposium as speakers and moderators.
GAT and SY coordinated and moderated the symposium. VAS drafted the
manuscript. All authors actively participated in critical revision of the
manuscript and approved the final version.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
Not applicable.
Author details
1Department of Radiation Molecular Epidemiology, Atomic Bomb Disease
Institute, Nagasaki University, 1-12-4 Sakamoto, 852-8523 Nagasaki, Japan.
2Imperial College London, Charing Cross Hospital, Fulham Palace Road,
London W6 8RF, UK. 3Radiation Medical Science Center for the Fukushima
Health Management Survey, Fukushima Medical University, 1 Hikarigaoka,
960-1295 Fukushima, Japan.
Received: 15 November 2016 Accepted: 11 January 2017
Saenko et al. Environmental Health  (2017) 16:3 Page 4 of 5
References
1. International Atomic Energy Agency. The Use of the International Nuclear and
Radiological Event Scale (INES) for event communication. 2014. http://www-
pub.iaea.org/MTCD/Publications/PDF/INES_web.pdf. Accessed 12 Nov 2016.
2. International Atomic Energy Agency. The Fukushima Daiichi accident. 2015.
http://www-pub.iaea.org/books/IAEABooks/10962/The-Fukushima-Daiichi-
Accident. Accessed 12 Nov 2016.
3. Radiation Medical Science Center for the Fukushima Health Management
Survey, Fukushima Medical Univeristy. Office of International Cooperation.
2012. http://fmu-global.jp/fukushima-health-management-survey/#report.
Accessed 12 Nov 2016.
4. Yasumura S, Hosoya M, Yamashita S, Kamiya K, Abe M, Akashi M, et al.
Study protocol for the Fukushima health management survey. J Epidemiol.
2012;22:375–83.
5. Suzuki S, Suzuki S, Fukushima T, Midorikawa S, Shimura H, Matsuzuka T,
et al. Comprehensive survey results of childhood thyroid ultrasound
examinations in Fukushima in the first four years after the Fukushima
Daiichi nuclear power plant accident. Thyroid. 2016;26:843–51.
6. Brenner AV, Tronko MD, Hatch M, Bogdanova TI, Oliynik VA, Lubin JH, et al.
I-131 dose response for incident thyroid cancers in Ukraine related to the
Chornobyl accident. Environ Health Perspect. 2011;119:933–9.
7. Bogdanova TI, Zurnadzhy LY, Nikiforov YE, Leeman-Neill RJ, Tronko MD,
Chanock S, et al. Histopathological features of papillary thyroid carcinomas
detected during four screening examinations of a Ukrainian-American
cohort. Br J Cancer. 2015;113:1556–64.
8. Ivanov VK, Kashcheev VV, Chekin SY, Maksioutov MA, Tumanov KA, Vlasov
OK, et al. Radiation-epidemiological studies of thyroid cancer incidence in
Russia after the Chernobyl accident (estimation of radiation risks, 1991–2008
follow-up period). Radiat Prot Dosimetry. 2012;151:489–99.
9. Nagataki S, Takamura N. Radioactive doses - predicted and actual - and
likely health effects. Clin Oncol (R Coll Radiol). 2016;28:245–54.
10. Ishikawa T, Yasumura S, Ozasa K, Kobashi G, Yasuda H, Miyazaki M, et al. The
Fukushima health management survey: estimation of external doses to
residents in Fukushima prefecture. Sci Rep. 2015. doi:10.1038/srep12712.
11. Tokonami S, Hosoda M, Akiba S, Sorimachi A, Kashiwakura I, Balonov M.
Thyroid doses for evacuees from the Fukushima nuclear accident. Sci Rep.
2012. doi:10.1038/srep00507.
12. Ivanov VK, Kashcheev VV, Chekin SY, Maksioutov MA, Tumanov KA, Meniailo
AN, et al. Thyroid cancer: lessons of Chernobyl and projections for
Fukushima. Radiat Risk (Russian). 2016;25:5–19.
13. Bogdanova T, Zurnadzhy L, LiVolsi VA, Williams ED, Ito M, Nakashima M,
et al. Thyroid cancer pathology in Ukraine after Chernobyl. In: Tronko M,
Bogdanova T, Saenko V, Thomas GA, Likhtarov I, Yamashita S, editors.
Thyroid cancer in ukraine after chernobyl. dosimetry, epidemiology,
pathology, molecular biology. Nagasaki: IN-TEX; 2014. p. 65–108.
14. Fridman M, Lam AK, Krasko O, Schmid KW, Branovan DI, Demidchik Y.
Morphological and clinical presentation of papillary thyroid carcinoma in
children and adolescents of Belarus: the influence of radiation exposure and
the source of irradiation. Exp Mol Pathol. 2015;98:527–31.
15. Rumyantsev PO, Saenko VA, Ilyin AA, Stepanenko VF, Rumyantseva UV,
Abrosimov AY, et al. Radiation exposure does not significantly contribute to
the risk of recurrence of Chernobyl thyroid cancer. J Clin Endocrinol Metab.
2011;96:385–93.
16. Reiners C, Biko J, Haenscheid H, Hebestreit H, Kirinjuk S, Baranowski O, et al.
Twenty-five years after Chernobyl: outcome of radioiodine treatment in
children and adolescents with very high-risk radiation-induced
differentiated thyroid carcinoma. J Clin Endocrinol Metab. 2013;98:3039–48.
17. Radiation Medical Science Center for the Fukushima Health Management
Survey, Fukushima Medical Univeristy. Office of International Cooperation.
The 23rd Prefectural Oversight Committee Meeting for Fukushima Health
Management Survey. 2016. http://fmu-global.jp/?wpdmdl=1632. Accessed
12 Nov 2016.
18. Radiation Medical Science Center for the Fukushima Health Management
Survey, Fukushima Medical Univeristy. Office of International Cooperation.
The 24th Prefectural Oversight Committee Meeting for Fukushima Health
Management Survey. 2016. http://fmu-global.jp/?wpdmdl=1889. Accessed
12 Nov 2016.
19. Tronko MD, Saenko VA, Shpak VM, Bogdanova TI, Suzuki S, Yamashita S. Age
distribution of childhood thyroid cancer patients in Ukraine after Chernobyl
and in Fukushima after the TEPCO-Fukushima Daiichi NPP accident. Thyroid.
2014;24:1547–8.
20. Takamura N, Orita M, Saenko V, Yamashita S, Nagataki S, Demidchik Y.
Radiation and risk of thyroid cancer: Fukushima and Chernobyl. Lancet
Diabetes Endocrinol. 2016;4:647.
21. Drozd VM, Saenko VA, Brenner AV, Drozdovitch V, Pashkevich VI, Kudelsky
AV, et al. Major factors affecting incidence of childhood thyroid cancer in
Belarus after the Chernobyl accident: do nitrates in drinking water play a
role? PLoS One. 2015;10:e0137226.
22. Ahn HS, Welch HG. South Korea’s thyroid-cancer “epidemic”–turning the
tide. N Engl J Med. 2015;373:2389–90.
23. World Health Organization. Health risk assessment from the nuclear
accident after the 2011 Great East Japan earthquake and tsunami, based on
a preliminary dose estimation. 2013. http://www.who.int/ionizing_radiation/
pub_meet/fukushima_risk_assessment_2013/en/. Accessed 12 Nov 2016.
24. United Nations Scientific Committee on the Effects of Atomic Radiation:
Sources and effects of ionizing radiation. UNSCEAR 2013 Report to the General
Assembly with scientific annexes. Volume I, Annex A: Levels and effects of
radiation exposure due to the nuclear accident after the 2011 Great east-Japan
earthquake and tsunami. 2014. http://www.unscear.org/docs/publications/
2013/UNSCEAR_2013_GA-Report.pdf. Accessed 12 Nov 2016.
25. International Atomic Energy Agency. Radiation protection and safety of
radiation sources: international basic safety standards. IAEA safety standards
series no. GSR part 3. Vienna: International Atomic Energy Agency; 2014.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Saenko et al. Environmental Health  (2017) 16:3 Page 5 of 5
